Sneaking-ligand fusion proteins attenuate serum transfer arthritis by endothelium-targeted NF-κB inhibition.
Sneaking-ligand fusion proteins attenuate serum transfer arthritis by endothelium-targeted NF-κB inhibition.
复制标题
潜行配体融合蛋白通过内皮靶向 NF-κB 抑制来减轻血清转移关节炎。
DOI:
10.1007/978-1-4939-2422-6_34
复制
发表时间:
2015
期刊:
影响因子:
--
通讯作者:
Voll,ReinhardE
中科院分区:
文献类型:
--
作者:
Sehnert,Bettina;Burkhardt,Harald;May,MichaelJ;Zwerina,Jochen;Voll,ReinhardE
The nuclear transcription factor κB (NF-κB) is a crucial mediator of the inflammatory and immune response. The contribution of dysregulated NF-κB is established in the pathogenesis of arthritis. Accordingly, NF-κB represents an attractive molecular target for the development of therapeutic interventions in inflammatory diseases. However, ubiquitous pharmacologic suppression of NF-κB activity is limited by the hazards of toxic side effects and profound immunosuppression. Cell type-specific NF-κB inhibition with the “sneaking-ligand” approach could identify disease-relevant cell types and improve risk-benefit ratios of therapeutic interventions. Vascular endothelial cells act as a gatekeeper and are crucial for leukocyte recruitment into sites of inflammation. The endothelium-specific NF-κB inhibitor SLC1 ameliorates serum transfer arthritis in mice and protects against inflammation and cartilage destruction. In this chapter, we describe the SLC1 treatment schedule in theK/BxNserum transfer arthritis and present the evaluation system to analyze arthritis severity and histopathological alterations.
影响因子:
16.8
作者:
Williams MR;Azcutia V;Newton G;Alcaide P;Luscinskas FW
通讯作者:
Luscinskas FW
DOI:
10.1073/pnas.1218219110
发表时间:
2013-10-08
影响因子:
11.1
作者:
Sehnert, Bettina;Burkhardt, Harald;Voll, Reinhard Edmund
通讯作者:
Voll, Reinhard Edmund
影响因子:
4.4
作者:
K. Terato;K. Hasty;R. Reife;M. Cremer;A. Kang;J. Stuart
通讯作者:
K. Terato;K. Hasty;R. Reife;M. Cremer;A. Kang;J. Stuart